Invention Grant
US08088925B2 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide-derivatives as factor Xa inhibitors
有权
杂芳基羧酸(氨磺酰基烷基)酰胺衍生物作为因子Xa抑制剂
- Patent Title: Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide-derivatives as factor Xa inhibitors
- Patent Title (中): 杂芳基羧酸(氨磺酰基烷基)酰胺衍生物作为因子Xa抑制剂
-
Application No.: US11940654Application Date: 2007-11-15
-
Publication No.: US08088925B2Publication Date: 2012-01-03
- Inventor: Michael Wagner , Matthias Urmann , Volkmar Wehner , Martin Lorenz , Armin Bauer , Marc Nazare , Hans Matter
- Applicant: Michael Wagner , Matthias Urmann , Volkmar Wehner , Martin Lorenz , Armin Bauer , Marc Nazare , Hans Matter
- Applicant Address: FR Paris
- Assignee: Sanofi-Aventis
- Current Assignee: Sanofi-Aventis
- Current Assignee Address: FR Paris
- Agency: Scully, Scott, Murphy & Presser, P.C.
- Agent Ronald G. Ort, Esq.
- Priority: EP05010929 20050520
- Main IPC: C07D401/02
- IPC: C07D401/02 ; C07D403/02 ; C07D333/10 ; C07D333/28 ; A61K31/4535 ; A61K31/381 ; A61K31/497

Abstract:
The present invention relates to compounds of the formula I, which exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses.
Public/Granted literature
- US20080167346A1 HETEROARYL-CARBOXYLIC ACID (SULFAMOYL ALKYL) AMIDE - DERIVATIVES AS FACTOR XA INHIBITORS Public/Granted day:2008-07-10
Information query